Pricing

Log inSign up

Foghorn Therapeutics

1 follower

‌

Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Their proprietary Gene Traffic Control platform gives them an integ... Read more

Industries

Biotechnology

Headquarters

Cambridge, United States

Employees

51-200

Links

Org chart

Adrian Gottschalk
CEO
Collapse
Samuel Agresta
Chief Medical Officer
Michael Lacascia
Chief Legal Officer
Steven Bellon
Chief Scientific Officer
Carlos Costa
Chief People Officer
Murphy Hentemann
VP, Program Leadership
Danette L. Daniels
Vice President, Protein Degradation Platform
Kevin Wilson
VP, Chemistry
Marina Nelen
VP, Drug Discovery
Karin Hellsvik
Vice President, Corporate Affairs & Investor Relations, Chief Of Staff To The CEO
Saurabh Sewak
Head Of Business Development And Vp, Corporate Development
Dan Dinu
Vice President, Head Of IT
Andrew Germain
Vice President, Legal
AQ
Alfonso Quintás-Cardama
Chief Medical Officer
Anna Rivkin
Chief Business Officer
Kristian F. Humer
Chief Financial Officer

Board & advisors

Scott Biller
Director
Doug Cole
Director
Simba Gill
Director
Cigall Kadoch
Director
Adam Koppel
Director
Michael Mendelsohn
Director
Ian Smith
Director
Lynne Parshall
Director
TL
Tom Lynch
Director
Charles L. Sawyers
Advisor
Gerald Crabtree
Advisor
Tony Kouzarides
Advisor
David Schenkein
Advisor

Teams

+13

Directors and Advisors

17 people · 0 jobs

+5

Leadership Team

9 people · 0 jobs

+7

Vice Presidents

11 people · 0 jobs

Offices

Similar companies

Sutro Biopharma

3 followers

Active Motif

3 followers

Dyno Therapeutics

4 followers

Janux Therapeutics

1 follower

Eikon Therapeutics

3 followers

Gilead Sciences

157 followers

Regeneron

124 followers

Illumina

78 followers

Agilent Technologies

78 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

44 followers

Explore companies